HRP970243B1 - Inhibition of matrix metalloproteases by substituted phenethyl compounds - Google Patents

Inhibition of matrix metalloproteases by substituted phenethyl compounds

Info

Publication number
HRP970243B1
HRP970243B1 HR970243A HRP970243A HRP970243B1 HR P970243 B1 HRP970243 B1 HR P970243B1 HR 970243 A HR970243 A HR 970243A HR P970243 A HRP970243 A HR P970243A HR P970243 B1 HRP970243 B1 HR P970243B1
Authority
HR
Croatia
Prior art keywords
inhibition
matrix metalloproteases
substituted phenethyl
compounds
phenethyl compounds
Prior art date
Application number
HR970243A
Other languages
English (en)
Inventor
Donald J Wolanin
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HRP970243A2 publication Critical patent/HRP970243A2/xx
Publication of HRP970243B1 publication Critical patent/HRP970243B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR970243A 1996-05-15 1997-05-09 Inhibition of matrix metalloproteases by substituted phenethyl compounds HRP970243B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64502696A 1996-05-15 1996-05-15

Publications (2)

Publication Number Publication Date
HRP970243A2 HRP970243A2 (en) 1998-04-30
HRP970243B1 true HRP970243B1 (en) 2002-06-30

Family

ID=24587359

Family Applications (1)

Application Number Title Priority Date Filing Date
HR970243A HRP970243B1 (en) 1996-05-15 1997-05-09 Inhibition of matrix metalloproteases by substituted phenethyl compounds

Country Status (24)

Country Link
EP (1) EP0907632B1 (xx)
JP (1) JP3305328B2 (xx)
CN (1) CN1124255C (xx)
AR (1) AR007100A1 (xx)
AT (1) ATE229497T1 (xx)
AU (1) AU727899B2 (xx)
BR (1) BR9709084A (xx)
CA (1) CA2253870C (xx)
CO (1) CO5070565A1 (xx)
DE (1) DE69717811T2 (xx)
DK (1) DK0907632T3 (xx)
ES (1) ES2188943T3 (xx)
HN (1) HN1997000071A (xx)
HR (1) HRP970243B1 (xx)
ID (1) ID17424A (xx)
PA (1) PA8429801A1 (xx)
PE (1) PE66298A1 (xx)
PT (1) PT907632E (xx)
SV (1) SV1997000037A (xx)
TN (1) TNSN97082A1 (xx)
TW (1) TW363056B (xx)
WO (1) WO1997043247A1 (xx)
YU (1) YU18497A (xx)
ZA (1) ZA974029B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288063B1 (en) * 1998-05-27 2001-09-11 Bayer Corporation Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
EP1140768A1 (en) 1998-12-30 2001-10-10 Bayer Aktiengesellschaft Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
EP1031349A1 (en) * 1999-02-25 2000-08-30 Bayer Aktiengesellschaft Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases
US7141607B1 (en) 2000-03-10 2006-11-28 Insite Vision Incorporated Methods and compositions for treating and inhibiting retinal neovascularization
FR2901320B1 (fr) * 2006-05-17 2008-07-04 Univ Savoie Etablissement Publ Dispositif miniaturise apte a fonctionner comme moteur ou refroidisseur selon un cycle thermodynamique de stirling
CA2944614A1 (en) 2014-04-03 2015-10-08 Bayer Pharma Aktiengesellschaft 2,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratoy tract diseases
EP3126339A1 (de) 2014-04-03 2017-02-08 Bayer Pharma Aktiengesellschaft 2,5-disubstituierte cyclopentancarbonsäuren und ihre verwendung
JP2017511319A (ja) 2014-04-03 2017-04-20 バイエル ファーマ アクチエンゲゼルシャフト キラル２，５−ジ置換されたシクロペンタンカルボン酸誘導体およびそれの使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784701A (en) * 1970-09-21 1974-01-08 American Cyanamid Co Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain
DE2112716A1 (de) * 1971-03-17 1972-10-05 Thomae Gmbh Dr K Neue 4-(4-Biphenylyl)-4-oxobuttersaeuren,ihre Salze und ihre Ester
US5789434A (en) * 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors

Also Published As

Publication number Publication date
EP0907632A1 (en) 1999-04-14
PE66298A1 (es) 1998-10-23
CA2253870A1 (en) 1997-11-20
HRP970243A2 (en) 1998-04-30
AU2938597A (en) 1997-12-05
TW363056B (en) 1999-07-01
SV1997000037A (es) 1999-01-14
HN1997000071A (es) 1997-06-18
JP3305328B2 (ja) 2002-07-22
AR007100A1 (es) 1999-10-13
DE69717811T2 (de) 2003-05-28
DK0907632T3 (da) 2003-04-07
EP0907632B1 (en) 2002-12-11
ATE229497T1 (de) 2002-12-15
ID17424A (id) 1997-12-24
PA8429801A1 (es) 2000-05-24
ZA974029B (en) 1998-02-19
DE69717811D1 (en) 2003-01-23
YU18497A (en) 1999-11-22
CN1124255C (zh) 2003-10-15
JPH11510517A (ja) 1999-09-14
BR9709084A (pt) 1999-08-03
CN1225624A (zh) 1999-08-11
AU727899B2 (en) 2001-01-04
ES2188943T3 (es) 2003-07-01
WO1997043247A1 (en) 1997-11-20
CO5070565A1 (es) 2001-08-28
TNSN97082A1 (fr) 2005-03-15
CA2253870C (en) 2004-01-06
PT907632E (pt) 2003-04-30

Similar Documents

Publication Publication Date Title
IL135574A0 (en) Substituted 4-amino-thiazol-2-yl compounds as cdk inhibitors
HRP960386B1 (en) Substituted benzylaminopiperidine compounds
AP9701021A0 (en) Novel compounds
EP0802908A4 (en) NEW COMPOUNDS
GB9507203D0 (en) Novel compounds
AU120921S (en) Water distributor
HRP970244B1 (en) Inhibition of matrix metalloproteases by 2-substit
PL332896A1 (en) Substituted tricyclic compounds
HRP970243B1 (en) Inhibition of matrix metalloproteases by substituted phenethyl compounds
GB9502870D0 (en) Chiral compounds
HRP970242A2 (en) Inhibition of matrix metalloproteases by 2-(omega-aroylalkyl)-4-biaryl-oxobutric acids
GB9713732D0 (en) Substituted triazinic compounds
GB2316076B (en) Chiral Compounds
GB9503717D0 (en) Novel compounds
GB9315343D0 (en) Sludge distributor
GB9507294D0 (en) Analine compounds
ZA96631B (en) Substituted phenyl compounds
IL127114A0 (en) Substituted heterocyclic compounds
ZA963470B (en) Novel compounds
GB9500262D0 (en) Novel compounds
GB9508957D0 (en) Novel compounds
GB9508956D0 (en) Novel compounds
GB9508955D0 (en) Novel compounds
GB9508010D0 (en) Novel compounds
GB9502051D0 (en) Novel compounds

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20040428

Year of fee payment: 8

PBON Lapse due to non-payment of renewal fee

Effective date: 20050510